Table 4. Target family profiles for top five drugs with largest changes in promiscuity.
Drug name | #Targets | #Families | Family list |
---|---|---|---|
Imatinib | 24 | 7 | ATP binding cassette transporters;
Carbonic anhydrases; Multi antimicrobial extrusion (MATE) transporters; NAD(P)H dehydrogenases (quinone); Organic cation transporters; Ser_Thr protein kinases; Tyr protein kinases |
Indomethacin | 16 | 10 | ATP binding cassette transporters;
Aldo/keto reductases; Glyoxalases I; Intercrines; Lipoxygenases; MAPEGs; Organic cation transporters; Organo anion transporters; Potassium ion channels; Short-chain dehydrogenases/reductases (SDR) |
Risperidone | 15 | 4 |
Monoamine GPCRs;
Multi antimicrobial extrusion (MATE) transporters; Organic cation transporters; Sodium:neurotransmitter symporters (SNF) |
Furosemide | 14 | 4 |
Bile acid:sodium symporters (BASS);
Carbonic anhydrases; Carboxylic acid GPCRs; Short-chain dehydrogenases/reductases (SDR) |
Dipyridamole | 12 | 5 |
ATP binding cassette transporters;
Multi antimicrobial extrusion (MATE) transporters; Organic cation transporters; Class C PPases; Phosphodiesterases |
For the top five drugs with largest changes in promiscuity over time, the total number of targets and families is reported. The family with the first target annotation of a drug is shown in bold. Target family abbreviation: MAPEG, membrane-associated proteins in eicosanoid and glutathione metabolism.